Paolo Fiorina

Paolo Fiorina has a diverse work experience in the field of Endocrinology. Paolo has held various roles in prestigious institutions and organizations. In 2004, they began their career as an Assistant Professor at the Harvard Medical School, specializing in Pediatric Endocrinology. In 2017, they joined the Università degli Studi di Milano as a Professor of Endocrinology and also became the Director of the International Center for T1D at the Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Ospedale Sacco. In the same year, they became the Chief of Endocrinology at Fatebenefratelli-Sacco-Macedonio Melloni-Buzzi Hospitals. In 2018, they co-founded Enthera Pharmaceuticals, a company focused on developing innovative therapies for autoimmune diseases. In 2019, they co-founded Altheia Science, an organization dedicated to scientific research. Through their various roles, Paolo Fiorina has made significant contributions to the field of Endocrinology and continues to drive advancements in medical research and treatment.

From 1987 to 2004, Paolo Fiorina attended Università degli Studi di Milano but did not obtain a degree or specialize in any particular field of study.